SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Jonsson R, Haga HJ, Gordon T. Sjögren's syndrome. In: KoopmanWJ, editor. Arthritis and allied conditions: a textbook of rheumatology. 14th ed. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 173659.
  • 2
    Hansen A, Lipsky PE, Dorner T. New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers [review]. Curr Opin Rheumatol 2003; 15: 56370.
  • 3
    Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease: the salivary glands of patients with Sjögren's syndrome. J Clin Invest 1998; 102: 93846.
  • 4
    Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmstrom P, Wahren-Herlenius M, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003; 48: 3187201.
  • 5
    Bahler DW, Swerdlow SH. Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjögren's syndrome) begin as nonmalignant antigen-selected expansions. Blood 1998; 91: 186472.
  • 6
    Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J, et al. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2002; 46: 216071.
  • 7
    Hansen A, Jacobi A, Pruss A, Kaufmann O, Scholze J, Lipsky PE, et al. Comparison of immunoglobulin heavy chain rearrangements between peripheral and glandular B cells in a patient with primary Sjögren's syndrome. Scand J Immunol 2003; 57: 4709.
  • 8
    Bohnhorst J, Bjorgan MB, Thoen JE, Natvig JB, Thompson KM. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome. J Immunol 2001; 167: 36108.
  • 9
    Bohnhorst JO, Thoen JE, Natvig JB, Thompson KM. Significantly depressed percentage of CD27+ (memory) B cells among peripheral blood B cells in patients with primary Sjögren's syndrome. Scand J Immunol 2001; 54: 4217.
  • 10
    Hansen A, Gosemann M, Pruss A, Reiter K, Ruzickova S, Lipsky PE, et al. Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome. Arthritis Rheum 2004; 50: 1897908.
  • 11
    Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases [review]. Blood 2000; 95: 303243.
  • 12
    Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity [review]. Immunity 2000; 12: 1217.
  • 13
    Hjelmstrom P. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines [review]. J Leukoc Biol 2001; 69: 3319.
  • 14
    Cuello C, Palladinetti P, Tedla N, di Girolamo N, Lloyd AR, McCluskey PJ, et al. Chemokine expression and leukocyte infiltration in Sjögren's syndrome. Br J Rheumatol 1998; 37: 77983.
  • 15
    Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, Crocker J, et al. Ectopic expression of the B cell–attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center–like structures in Sjögren's syndrome. Arthritis Rheum 2001; 44: 263341.
  • 16
    Salomonsson S, Larsson P, Tengner P, Mellquist E, Hjelmstrom P, Wahren-Herlenius M. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Scand J Immunol 2002; 55: 33642.
  • 17
    Xanthou G, Polihronis M, Tzioufas AG, Paikos S, Sideras P, Moutsopoulos HM. “Lymphoid” chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation. Arthritis Rheum 2001; 44: 40818.
  • 18
    Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S. Involvement of the interferon-γ–induced T cell–attracting chemokines, interferon-γ–inducible 10-kd protein (CXCL10) and monokine induced by interferon-γ (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Arthritis Rheum 2002; 46: 273041.
  • 19
    Mason GI, Hamburger J, Bowman S, Matthews JB. Salivary gland expression of transforming growth factor β isoforms in Sjögren's syndrome and benign lymphoepithelial lesions. Mol Pathol 2003; 56: 529.
  • 20
    Bowman EP, Kuklin NA, Youngman KR, Lazarus NH, Kunkel EJ, Pan J, et al. The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J Exp Med 2002; 195: 26975.
  • 21
    Fox RI, Saito I. Criteria for diagnosis of Sjögren's syndrome [review]. Rheum Dis Clin North Am 1994; 20: 391407.
  • 22
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al., and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 5548.
  • 23
    Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000; 165: 59709.
  • 24
    Ruzickova S, Pruss A, Odendahl M, Wolbart K, Burmester GR, Scholze J, et al. Chronic lymphocytic leukemia preceded by cold agglutinin disease: intraclonal immunoglobulin light-chain diversity in VH4-34 expressing single leukemic B cells [published erratum appears in Blood 2003;101:1676]. Blood 2002; 100: 341922.
  • 25
    Shi GX, Harrison K, Wilson GL, Moratz C, Kehrl JH. RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13. J Immunol 2002; 169: 250715.
  • 26
    Hauser AE, Debes GF, Arce S, Cassese G, Hamann A, Radbruch A, et al. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J Immunol 2002; 169: 127782.
  • 27
    Brandes M, Legler DF, Spoerri B, Schaerli P, Moser B. Activation-dependent modulation of B lymphocyte migration to chemokines. Int Immunol 2000; 12: 128592.
  • 28
    Dobner T, Wolf I, Emrich T, Lipp M. Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma. Eur J Immunol 1992; 22: 27959.
  • 29
    Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 1998; 187: 65560.
  • 30
    Bohnhorst JO, Bjorgan MB, Thoen JE, Jonsson R, Natvig JB, Thompson KM. Abnormal B cell differentiation in primary Sjögren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with serum IgG concentration. Clin Immunol 2002; 103: 7988.
  • 31
    Kehrl JH. Heterotrimeric G protein signaling: roles in immune function and fine-tuning by RGS proteins [review]. Immunity 1998; 8: 110.
  • 32
    Bowman EP, Campbell JJ, Soler D, Dong Z, Manlongat N, Picarella D, et al. Developmental switches in chemokine response profiles during B cell differentiation and maturation. J Exp Med 2000; 191: 130318.
  • 33
    Bleul CC, Schultze JL, Springer TA. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J Exp Med 1998; 187: 75362.
  • 34
    Wehrli N, Legler DF, Finke D, Toellner KM, Loetscher P, Baggiolini M, et al. Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes. Eur J Immunol 2001; 31: 60916.
  • 35
    Medina F, Segundo C, Campos-Caro A, Gonzalez-Garcia I, Brieva JA. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 2002; 99: 215461.
  • 36
    Honczarenko M, Douglas RS, Mathias C, Lee B, Ratajczak MZ, Silberstein LE. SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells. Blood 1999; 94: 29908.
  • 37
    Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Quin S, et al. The α-chemokine, stromal cell-derived factor-1α, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 1998; 273: 2316975.
  • 38
    Nanki T, Lipsky PE. Cutting edge: stromal cell derived factor-1 is a costimulator for CD4+ T cell activation. J Immunol 2000; 164: 50104.
  • 39
    Nanki T, Lipsky PE. Stimulation of T-cell activation by CXCL12/stromal cell derived factor-1 involves a G-protein mediated signaling pathway. Cell Immunol 2001; 214: 14554.
  • 40
    Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor BRL1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996; 87: 103747.
  • 41
    Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles [letter]. Nature 2000; 406: 30914.
  • 42
    Ansel KM, Cyster JG. Chemokines in lymphopoiesis and lymphoid organ development [review]. Curr Opin Immunol 2001; 13: 1729.